Ligandis works according to current guidelines for quality assurance in laboratory medical and analytical processes [1,2]. These include process-accompanying specifications from the time of sample collection (preanalytics), through the analysis, to the analysis result (postanalytics). Furthermore, the intensive consultation of our customers prior to the analysis as well as for the later interpretation of the data is essential for quality assurance.
EMA Guideline on bioanalytical method validation, Release July 21, 2011 (Europe)
FDA Guidance for Industry: Bioanalytical Method Validation, Release May 2001 (USA)